Dorsal Raphe Nucleus is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Dorsal Raphe Nucleus (DRN) is the largest serotonergic nucleus in the brain and a major source of serotonin (5-hydroxytryptamine, 5-HT) to the forebrain. It plays critical roles in mood regulation, arousal, anxiety, and various cognitive functions.
The Dorsal Raphe Nucleus is located in the midbrain, at the ventral aspect of the cerebral aqueduct. It contains the largest population of serotonergic neurons in the brain and projects to nearly all forebrain regions.
| Property | Value |
|---|---|
| Location | Midbrain, ventral to cerebral aqueduct, rostral to median raphe |
| Subdivisions | Dorsal, lateral, ventral parts |
| Cell Types | Serotonergic neurons, dopaminergic, GABAergic, glutamatergic |
| Neurotransmitters | Serotonin, dopamine, GABA, glutamate |
| Primary Afferents | Prefrontal cortex, amygdala, hypothalamus |
| Primary Efferents | Cortex, striatum, thalamus, hippocampus, amygdala |
The DRN contains heterogeneous neuronal populations:
The nucleus shows regional specialization.
Single-nucleus RNA seq reveals:
The DRN is targeted by:
The study of Dorsal Raphe Nucleus has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Hornung JP. The human raphe nuclei and the serotonergic system. J Chem Neuroanat. 2003;26(4):331-343.
[2] Descarries L, et al. The dorsal raphe nucleus. In: Handbook of Chemical Neuroanatomy. 2014.
[3] Michelsen KA, et al. Histochemical and functional anatomy of the rat dorsal raphe nucleus. J Comp Neurol. 2008;506(4):583-600.
[4] Belmer A, et al. The dorsal raphe nucleus. Curr Opin Neurobiol. 2020;60:144-152.
[5] Thompson B, et al. Serotonergic dysfunction in Alzheimer's disease. Ann Neurol. 2020.
[6] Braak H, et al. Amygdala pathology in Parkinson's disease. Acta Neuropathol. 1994;88(2):128-135.
[7] Mayberg HS, et al. Limbic-circuits in depression. Psychiatr Ann. 1995;25(12):795-803.
[8] Hamani C, et al. Deep brain stimulation for treatment-resistant depression. Am J Psychiatry. 2010;167(12):1437-1444.